American Journal Of Cardiovascular Drugs

DAPT Plus Cilostazol is Better Than Traditional DAPT or Aspirin Plus Ticagrelor as Elective PCI for Intermediate-to-Highly Complex Cases: Prospective, Randomized, PRU-Based Study in Taiwan

Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials

Does Coenzyme Q10 Supplementation Mitigate Statin-Associated Muscle Symptoms? Pharmacological and Methodological Considerations

Ivabradine in Postural Orthostatic Tachycardia Syndrome: Preliminary Experience in Children

Atrial Fibrillation in Patients with Heart Failure: Current State and Future Directions

Review of Direct Oral Anticoagulants and Guide for Effective Drug Utilization

Assessment and Management of Patients with Hyperlipidemia Referred for Initiation of PCSK9 Inhibitor Therapy: A Lipid Clinic Experience

A Literature Review of Genetic Markers Conferring Impaired Response to Cardiovascular Drugs

Self-Reported Non-adherence to Medication in Japanese Patients with Cardiovascular Diseases

Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry